About Us

In our fast-paced world, a company’s value derives from its capabilities to contribute economically,socially, and culturally as a member of the globalcommunity.

Hisamitsu Pharmaceutical has been engaged in the pharmaceutical industry since 1847 and has in the meantime become one of Japan’s leading companies and health campaigners through its providing medicines, in particular external pain relief patches.Our flagship product, SALONPAS_®, is known worldwide as a pioneer in the field of transdermal patches,and has been trademarked in over 100 countries.Hisamitsu also aims to bring new benefits to drugs in other fields by converting pharmaceutical substances into transdermal patches.We continue to promote the development of products with an eye towards global markets.

Our environment is now in the midst of a dramatic paradigm shift with ever declining birthrate and aging population, advancement of information technologies, and diversified values. In order to catch up with such changes and meet a variety of customer needs, Hisamitsu now has a new progressive mission, Promoting “TE-A-TE” Culture Worldwide, and started “the 7th Medium-term Management Policy” - Hisamitsu Transformation 2025 to ensure the implementation of our business strategies. Under the new company mission and the medium-term management policy, we will push forward a wide variety of businesses with not only topical and transdermal patches but also various products and services to contribute to improved QOL (quality of life) of the people all around the world.

We will also proactively engage ourselves in ESG (environment, society, and governance) and SDGs (sustainable development goals) to solve societal issues and improve our corporate value while contributing to development of sustainable society.

We would appreciate very much for your continuous support.